|Age:||-1 years or older|
|Keywords:||lung cancer, non-small cell lung cancer, cancer|
|Type:||Drug study, Phase 2|
The study team will make sure you qualify to take part in the study. Qualified participants will receive detailed information about the study. This may include a list of study-related tests and procedures.
Patients must have pathologically proven non-small cell lung cancer (all histologic types) confirmed by tumor biopsy and/or fine-needle aspiration. Disease must be Stage IV as defined in Section 4.0, or recurrent. The primary diagnosis of non-small cell lung cancer should be established using the current WHO/IASLC-classification of Thoracic Malignancies. (13) All histologies, including mixed, are allowed.
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.